Future Pharma Private Limited
About Future Pharma Private Limited
Data last updated:
Future Pharma Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85120UP2009PTC036892. Its GSTIN is 09AABCF3392E1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Krishan Gopal Gupta and Lokesh Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 119/41 Naseemabad Darshan Purwa, Kanpur, Uttar Pradesh, India – 208012.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.22 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹11.82 Lakh (net margin 1.3%) and EBITDA of ₹13.77 Lakh (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 26% over five years.
The company has about 273 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Future Pahrma. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹10 Lakh on record. Court records list 7 cases involving the company, including 7 filed by the company; 4 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address119/41 Naseemabad Darshan Purwa, Kanpur, Uttar Pradesh, India – 208012
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Future Pharma Private Limited
The main business activity of Future Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Future Pharma Private Limited FY 2025 filings available
Future Pharma Private Limited reported revenue of ₹9.22 Cr (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Future Pharma Private Limited
Revenue rose 17% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 26%. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Future Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹13.77 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.82 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Future Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Future Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Future Pharma Private Limited
Future Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Poddar Pharmaceuticals Private Limited | ₹9.25 Cr (FY 2024) | •••• | •••• | 83.0% | •••• | Uttar Pradesh, India |
| Thio Chemi Private Limited | ₹9.24 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Coimbatore, Tamil Nadu, India |
| Radicool Pharmaceutical Private Limited | ₹9.23 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | New Delhi, Delhi, India |
| Dorizoe Lifesciences Limited | ₹9.23 Cr (FY 2017) | •••• | •••• | 21.0% | •••• | Ahmedabad, Gujarat, India |
| Daeiou Pharmaceuticals Private Limited | ₹9.23 Cr (FY 2023) | •••• | •••• | 3.0% | •••• | Puducherry, India |
| Future Pharma Private Limited this company | ₹9.22 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Kanpur, Uttar Pradesh, India |
| Gloss Pharmaceuticals Private Limited | ₹9.22 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Uttar Pradesh, India |
| Elegant Chemical Enterprises Pvt Ltd | ₹9.21 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| Tamman Titoe Pharma Private Limited | ₹9.2 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Chennai, Tamil Nadu, India |
| Zoe Healthcare Private Limited | ₹9.19 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | Kharghar, Maharashtra, India |
| Ananjay Pharmaceuticals Private Limited | ₹9.18 Cr (FY 2025) | •••• | •••• | 61.0% | •••• | Bhopal, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Future Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Future Pharma Private Limited
Future Pharma Private Limited is audited by NIKHIL R.C. GUPTA & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NIKHIL R.C. GUPTA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Future Pharma Private Limited
Future Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishan Gopal Gupta | Director | 27 Feb 2009 | 17 Years 7 Months | Current |
| Lokesh Gupta | Director | 27 Feb 2009 | 17 Years 7 Months | Current |
| Manoj Kumar Gupta | Director | 27 Feb 2009 | 17 Years 7 Months | Current |
Ownership and Shareholding of Future Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Future Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Sep 2024 | Others | ₹2 Cr | Open |
| 30 Oct 2019 | Others | ₹10 Lakh | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Future Pharma Private Limited
Future Pharma Private Limited has 7 court cases on record: 7 filed by Future Pharma. 4 cases are pending and 3 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 0 | 4 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kanpur Nagar, Uttar Pradesh | Criminal case | Filed by the company against Foster Healthcare Private Limited | Pending |
| District court, Kanpur Nagar, Uttar Pradesh | Criminal case | Filed by the company against an individual | Pending |
| District court, Kanpur Nagar, Uttar Pradesh | Criminal case | Filed by the company against an individual | Pending |
| District court, Kanpur Nagar, Uttar Pradesh | Court case (Crl. Case) | Filed by the company against an individual | Pending |
| District court, Kanpur Nagar, Uttar Pradesh | Criminal case | Filed by the company against G.G. Pharma | Disposed |
Full case history
All 7 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Future Pharma Private Limited
Future Pharma operates one associated brand: Future Pahrma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products are manufactured and distributed by Future Pharma, focusing on global standards and affordability. | futurepharma.co.in |
Employees and EPFO Compliance at Future Pharma Private Limited
Future Pharma Private Limited has a workforce of 273 employees as of Apr 03, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Future Pharma Private Limited
Future Pharma Private Limited has 3 board changes on record since 2009: 3 appointments. The latest: Krishan Gopal Gupta was appointed as Director on 27 Feb 2009.
Credit Ratings, Litigation & Regulatory Alerts for Future Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Future Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Future Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Future Pharma Private Limited
Future Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCF3392E1ZP | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Future Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Future Pharma Private Limited
Future Pharma is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 February 2009 (17+ years old) and is registered under CIN U85120UP2009PTC036892.
Future Pharma reported revenue of ₹9.22 Cr for FY 2025 (up 17% YoY).
Future Pharma has 3 current directors:
- Krishan Gopal Gupta - Director
- Lokesh Gupta - Director
- Manoj Kumar Gupta - Director
Future Pharma reported a net profit of ₹11.82 Lakh (net margin 1.3%) and EBITDA of ₹13.77 Lakh (EBITDA margin 1.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Future Pharma is 23% over three years and -26% over five years. In the latest year (FY 2025) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Future Pharma is 09AABCF3392E1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Future Pharma is U85120UP2009PTC036892. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Future Pharma has 7 court cases on record: 7 filed by the company. 4 are pending.
Future Pharma was incorporated on 27 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Future Pharma by revenue are Poddar Pharmaceuticals Private Limited, Thio Chemi Private Limited, Radicool Pharmaceutical Private Limited, Dorizoe Lifesciences Limited, Daeiou Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Krishan Gopal Gupta was appointed as Director on 27 Feb 2009. Lokesh Gupta was appointed as Director on 27 Feb 2009. Manoj Kumar Gupta was appointed as Director on 27 Feb 2009.